These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25228048)

  • 21. [Registries of myocardial infarction in Germany. Consequences for drug therapy of patients with acute ST elevation myocardial infarction].
    Zeymer U; Zahn R; Senges J; Gitt A
    Internist (Berl); 2010 Oct; 51(10):1324-7, 1329. PubMed ID: 20725707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative outcomes after unprotected left main stem percutaneous coronary intervention: a national linked cohort study of 5,065 acute and elective cases from the BCIS Registry (British Cardiovascular Intervention Society).
    Almudarra SS; Gale CP; Baxter PD; Fleming SJ; Brogan RA; Ludman PF; de Belder MA; Curzen NP;
    JACC Cardiovasc Interv; 2014 Jul; 7(7):717-30. PubMed ID: 25060013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age differences in the adherence to treatment guidelines and outcome in patients with ST-elevation myocardial infarction.
    Gottlieb S; Behar S; Schwartz R; Harpaz D; Shotan A; Zahger D; Hod H; Tzivoni D; Moriel M;
    Arch Gerontol Geriatr; 2011; 52(1):118-24. PubMed ID: 20399515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of a Regional Network for ST-Segment-Elevation Myocardial Infarction (STEMI) Care and 30-Day Mortality in a Low- to Middle-Income City in Brazil: Findings From Salvador's STEMI Registry (RESISST).
    Filgueiras Filho NM; Feitosa Filho GS; Solla DJF; Argôlo FC; Guimarães PO; Paiva Filho IM; Carvalho LGM; Teixeira LS; Rios MNO; Câmara SF; Novais VO; Barbosa LS; Ballalai CS; De Lúcia CV; Granger CB; Newby LK; Lopes RD
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29980522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines.
    Pandey A; Golwala H; Hall HM; Wang TY; Lu D; Xian Y; Chiswell K; Joynt KE; Goyal A; Das SR; Kumbhani D; Julien H; Fonarow GC; de Lemos JA
    JAMA Cardiol; 2017 Jul; 2(7):723-731. PubMed ID: 28445559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation, management and mortality after a first MI in people with and without asthma: A study using UK MINAP data.
    Pinto P; Rothnie KJ; Lui K; Timmis A; Smeeth L; Quint JK
    Chron Respir Dis; 2018 Feb; 15(1):60-70. PubMed ID: 28393591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ST-Elevation Acute Myocardial Infarction in Australia-Temporal Trends in Patient Management and Outcomes 1999-2016.
    Aliprandi-Costa B; Morgan L; Snell LC; D Souza M; Kritharides L; French J; Brieger D; Ranasinghe I
    Heart Lung Circ; 2019 Jul; 28(7):1000-1008. PubMed ID: 30006115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute coronary syndromes: clinical characteristics, management, and outcomes at the American University of Beirut Medical Center, 2002-2005.
    Abdallah M; Karrowni W; Shamseddeen W; Itani S; Kobeissi L; Ghazzal Z; Alam S; Dakik HA
    Clin Cardiol; 2010 Jan; 33(1):E6-E13. PubMed ID: 20014175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction.
    Shen L; Shah BR; Nam A; Holmes D; Alexander KP; Bhatt DL; Ho PM; Peterson ED; He B; Roe MT
    Am Heart J; 2014 Jun; 167(6):840-5. PubMed ID: 24890533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction.
    Arnold SV; Spertus JA; Masoudi FA; Daugherty SL; Maddox TM; Li Y; Dodson JA; Chan PS
    J Am Coll Cardiol; 2013 Nov; 62(19):1791-801. PubMed ID: 23973701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of gender on treatment and clinical outcomes in acute ST elevation myocardial infarction patients in Thailand.
    Srichaiveth B; Ruengsakulrach P; Visudharom K; Sanguanwong S; Tangsubutr W; Insamian P
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():65-73. PubMed ID: 18431888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-dependent improvements in survival after hospitalisation with acute myocardial infarction: an analysis of the Myocardial Ischemia National Audit Project (MINAP).
    Alabas OA; Allan V; McLenachan JM; Feltbower R; Gale CP
    Age Ageing; 2014 Nov; 43(6):779-85. PubMed ID: 24362555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of in-hospital mortality for patients admitted with ST-elevation myocardial infarction: a real-world study using the Myocardial Infarction National Audit Project (MINAP) database.
    Gale CP; Manda SO; Batin PD; Weston CF; Birkhead JS; Hall AS
    Heart; 2008 Nov; 94(11):1407-12. PubMed ID: 18070941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study.
    Gitt AK; Schiele R; Wienbergen H; Zeymer U; Schneider S; Gottwik MG; Senges J;
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S343-7. PubMed ID: 14704866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy for ST-segment elevation myocardial infarction patients who present late or are ineligible for reperfusion therapy.
    Cohen M; Boiangiu C; Abidi M
    J Am Coll Cardiol; 2010 May; 55(18):1895-906. PubMed ID: 20430260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany].
    Wagner S; Schneider S; Schiele R; Fischer F; Dehn H; Grube R; Becker G; Baumgärtel B; Altmann E; Senges J
    Z Kardiol; 1999 Oct; 88(10):857-67. PubMed ID: 10552190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.